Mid-ventricular variant of dobutamine-induced stress cardiomyopathy

Introduction: Dobutamine stress testing is a commonly used modality in detecting and estimating the prognosis in coronary artery disease (CAD). Although it is well tolerated by most patients, adverse events have been reported. Rarely, transient wall motion abnormalities can occur in the absence of o...

Full description

Bibliographic Details
Main Authors: Satish Chandraprakasam, Swapna Kanuri, Claire Hunter
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Research in Cardiovascular Medicine
Subjects:
Online Access:http://www.rcvmonline.com/article.asp?issn=2251-9572;year=2015;volume=4;issue=2;spage=2;epage=2;aulast=Chandraprakasam;type=0
_version_ 1818553331543441408
author Satish Chandraprakasam
Swapna Kanuri
Claire Hunter
author_facet Satish Chandraprakasam
Swapna Kanuri
Claire Hunter
author_sort Satish Chandraprakasam
collection DOAJ
description Introduction: Dobutamine stress testing is a commonly used modality in detecting and estimating the prognosis in coronary artery disease (CAD). Although it is well tolerated by most patients, adverse events have been reported. Rarely, transient wall motion abnormalities can occur in the absence of obstructive CAD to suggest stress cardiomyopathy. Case Presentation: We report a 48-year-old female with intermittent chest pain. Her physical exam, cardiac enzymes and transthoracic echocardiogram were unremarkable. She underwent dobutamine stress echocardiogram to rule out obstructive CAD. After 40 micrograms (mcg)/kg/minute and 0.5 mg atropine, she complained of intense chest pain and became hypertensive. Stress echocardiogram demonstrated mid-anterior and mid-septal hypokinesis. Emergent coronary angiogram demonstrated normal coronaries. Left ventricular angiogram in the right anterior oblique projection revealed mid-ventricular ballooning during systole with apical and basal hypercontractility. Patient demonstrated excellent recovery with expectant management. Conclusions: The mechanism of mid-variant of Dobutamine-induced stress cardiomyopathy remains unclear. We think that multiple mechanisms are involved and this risk should be considered in patients with comorbid psychiatric conditions and with use of centrally acting stimulants.
first_indexed 2024-12-12T09:24:29Z
format Article
id doaj.art-ed9d272a63cb4e869441fc1b061b4047
institution Directory Open Access Journal
issn 2251-9572
2251-9580
language English
last_indexed 2024-12-12T09:24:29Z
publishDate 2015-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Research in Cardiovascular Medicine
spelling doaj.art-ed9d272a63cb4e869441fc1b061b40472022-12-22T00:29:05ZengWolters Kluwer Medknow PublicationsResearch in Cardiovascular Medicine2251-95722251-95802015-01-01422210.5812/cardiovascmed.4(2)2015.25223Mid-ventricular variant of dobutamine-induced stress cardiomyopathySatish ChandraprakasamSwapna KanuriClaire HunterIntroduction: Dobutamine stress testing is a commonly used modality in detecting and estimating the prognosis in coronary artery disease (CAD). Although it is well tolerated by most patients, adverse events have been reported. Rarely, transient wall motion abnormalities can occur in the absence of obstructive CAD to suggest stress cardiomyopathy. Case Presentation: We report a 48-year-old female with intermittent chest pain. Her physical exam, cardiac enzymes and transthoracic echocardiogram were unremarkable. She underwent dobutamine stress echocardiogram to rule out obstructive CAD. After 40 micrograms (mcg)/kg/minute and 0.5 mg atropine, she complained of intense chest pain and became hypertensive. Stress echocardiogram demonstrated mid-anterior and mid-septal hypokinesis. Emergent coronary angiogram demonstrated normal coronaries. Left ventricular angiogram in the right anterior oblique projection revealed mid-ventricular ballooning during systole with apical and basal hypercontractility. Patient demonstrated excellent recovery with expectant management. Conclusions: The mechanism of mid-variant of Dobutamine-induced stress cardiomyopathy remains unclear. We think that multiple mechanisms are involved and this risk should be considered in patients with comorbid psychiatric conditions and with use of centrally acting stimulants.http://www.rcvmonline.com/article.asp?issn=2251-9572;year=2015;volume=4;issue=2;spage=2;epage=2;aulast=Chandraprakasam;type=0Cardiomyopathy; Takotsubo Cardiomyopathy; EchocardiographyStress
spellingShingle Satish Chandraprakasam
Swapna Kanuri
Claire Hunter
Mid-ventricular variant of dobutamine-induced stress cardiomyopathy
Research in Cardiovascular Medicine
Cardiomyopathy; Takotsubo Cardiomyopathy; Echocardiography
Stress
title Mid-ventricular variant of dobutamine-induced stress cardiomyopathy
title_full Mid-ventricular variant of dobutamine-induced stress cardiomyopathy
title_fullStr Mid-ventricular variant of dobutamine-induced stress cardiomyopathy
title_full_unstemmed Mid-ventricular variant of dobutamine-induced stress cardiomyopathy
title_short Mid-ventricular variant of dobutamine-induced stress cardiomyopathy
title_sort mid ventricular variant of dobutamine induced stress cardiomyopathy
topic Cardiomyopathy; Takotsubo Cardiomyopathy; Echocardiography
Stress
url http://www.rcvmonline.com/article.asp?issn=2251-9572;year=2015;volume=4;issue=2;spage=2;epage=2;aulast=Chandraprakasam;type=0
work_keys_str_mv AT satishchandraprakasam midventricularvariantofdobutamineinducedstresscardiomyopathy
AT swapnakanuri midventricularvariantofdobutamineinducedstresscardiomyopathy
AT clairehunter midventricularvariantofdobutamineinducedstresscardiomyopathy